Uremic encephalopathy (UE) is an acquired metabolic complication of renal failure with accumulation of toxic metabolites which cross the blood brain barrier to cause cerebral dysfunction. It manifests in the form of acute or subacute neurological features which are usually reversible [1] [2] [3] [4]. Initial symptoms of UE are nausea, vomiting, loss of appetite, drowsiness, inability to concentrate emotional lability, irritability, confusion progressing, if untreated, to seizures, delirium, myoclonus, asterixis and coma [5].

Once treatment of renal dysfunction is instituted patients may present with impaired cognition, generalized asthenia, and peripheral neuropathy [6]. Renal dialysis in chronic renal failure or end-stage renal disease is associated with dysequilibrium and dementia. Dialysis-associated disequilibrium is characterized by nausea, muscle cramps, altered sensorium, and seizures while dialysis-associated dementia is a progressive condition with increased incidence of mortality seen in patients on long-term hemodialysis. Dialysis encephalopathy can be either sporadic, epidemic or associated with pediatric renal disease [6].

Workup in a patient presenting with confusion, nystagmus, hyperreflexia, clonus, asterixis and coma should include a thorough history and neurological examination. An ophthalmic examination may reveal papilledema. UE can be evaluated with many cognitive tests to measure psychomotor speed, short-term recognition and ability to make simple decisions. Laboratory tests are likely to show anemia (due to chronic renal disease), leukocytosis (if there is an underlying infection), with renal function tests [7] showing severely elevated blood urea nitrogen and serum creatinine levels. Serum electrolyte and glucose levels should be ordered to evaluate sodium and blood glucose levels to exclude electrolyte abnormalities, hyperglycemia, and hyperosmolar syndromes. Serum calcium, magnesium, phosphate and parathyroid hormone levels should be checked to exclude other causes of encephalopathy. A toxicology screen should also be performed. An electroencephalogram (EEG) obtained in UE is likely to show a disorganized pattern with absent alpha waves and occasional theta and delta waves.

Imaging studies like magnetic resonance imaging (MRI) or computed tomography (CT) scan of the head are only indicated to exclude intracranial tumors and hematoma or hemorrhage. CT scan findings are not specific for UE but MRI will reveal an increase in signal intensity either in the cerebral cortex or in the basal ganglia. [8] [9]. This is also called the lentiform fork sign. Based on the MRI findings, UE has been classified into two varieties [10]:

• Cortical: involvement of the cortex is more common, develops in any patient with UE, is associated with posterior reversible encephalopathy syndrome (PRES) and not affected by diabetes mellitus [1] [3] [4]. MRI shows mainly vasogenic edema [11].
• Bilateral basal ganglia involvement: this is rare and usually seen in Asian patients with diabetes mellitus [1] [2] [3] [12] [13]. MRI shows vasogenic as well as cytotoxic edema [11].

The primary treatment for uremic encephalopathy is addressing the underlying kidney dysfunction. This often involves dialysis, a procedure that removes waste products and excess fluid from the blood. Dialysis can be performed on an ongoing basis for chronic kidney disease or as an emergency measure in acute cases. In addition to dialysis, managing electrolyte imbalances and ensuring proper nutrition are important aspects of treatment. Medications may be used to control symptoms such as seizures or agitation.

The prognosis for uremic encephalopathy largely depends on the severity of the kidney dysfunction and the timeliness of treatment. With appropriate management, many patients experience significant improvement in their neurological symptoms. However, if left untreated, the condition can lead to permanent brain damage or be life-threatening. Chronic kidney disease patients may require long-term dialysis or a kidney transplant to prevent recurrence.

Uremic encephalopathy is primarily caused by the accumulation of waste products in the blood due to impaired kidney function. This can occur in both acute and chronic kidney failure. Factors contributing to kidney dysfunction include diabetes, hypertension, glomerulonephritis (inflammation of the kidney's filtering units), and polycystic kidney disease. Acute kidney injury can result from severe dehydration, infections, or exposure to certain medications or toxins.

Uremic encephalopathy is most commonly seen in patients with end-stage renal disease (ESRD), affecting those who have not yet started or are inadequately managed on dialysis. It can also occur in patients with acute kidney injury. The condition is more prevalent in older adults and those with underlying health conditions such as diabetes and hypertension, which are risk factors for kidney disease.

The pathophysiology of uremic encephalopathy involves the accumulation of uremic toxins, such as urea and creatinine, in the blood. These toxins can cross the blood-brain barrier and disrupt normal brain function. The exact mechanisms are not fully understood, but it is believed that these toxins interfere with neurotransmitter function and cause oxidative stress, leading to neuronal damage and altered brain activity.

Preventing uremic encephalopathy involves managing the underlying causes of kidney disease. This includes controlling blood sugar levels in diabetes, maintaining healthy blood pressure, and avoiding medications or substances that can harm the kidneys. Regular monitoring of kidney function in at-risk individuals can help detect problems early and prevent the progression to severe kidney dysfunction.

Uremic encephalopathy is a serious neurological condition resulting from the accumulation of waste products in the blood due to kidney failure. It presents with a range of symptoms from confusion to seizures and requires prompt treatment, primarily through dialysis, to remove toxins. Understanding the underlying causes and risk factors is crucial for prevention and management. With timely intervention, many patients can recover from the neurological effects, although ongoing management of kidney disease is often necessary.

If you or a loved one is experiencing symptoms such as confusion, difficulty concentrating, or unusual drowsiness, it may be related to kidney function. Uremic encephalopathy is a condition where the brain is affected by toxins that the kidneys are unable to filter out. Treatment typically involves dialysis to clean the blood and manage symptoms. It's important to work closely with healthcare providers to monitor kidney health and prevent complications. Regular check-ups and managing conditions like diabetes and high blood pressure can help maintain kidney function and reduce the risk of developing uremic encephalopathy.

1. Wang HC, Cheng SJ. The syndrome of acute bilateral basal ganglia lesions in diabetic uremic patients. J Neurol. 2003;250:948–955.
2. Kim TK, Seo SI, Kim JH, Lee NJ, Seol HY. Diffusion-weighted magnetic resonance imaging in the syndrome of acute bilateral basal ganglia lesions in diabetic uremia. Mov Disord. 2006;21:1267–1270.
3. Wang HC, Brown P, Lees AJ. Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord. 1998;13:952–957.
4. Prüss H, Siebert E, Masuhr F. Reversible cytotoxic brain edema and facial weakness in uremic encephalopathy. J Neurol. 2009;256:1372–1373.
5. Chertow GM, Marsden PA et.al. Brenner and Rector's The Kidney. Saunders. ISBN:1416061932.
6. Mahoney CA, Arieff AI. Uremic encephalopathies: clinical, biochemical and experimental features. Am J. Kidney Dis. 1982 Nov; 2(3):324 -36
7. Yamamoto T, Satomura K, Okada S, et al. Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli O157. Pediatr Int. 2009 Apr; 51(2):216-9.
8. Schmidt M, Sitter T, Lederer SR, Held E, Schiffl H. Reversible MRI changes in a patient with uremic encephalopathy. J Nephrol. 2001 Sep-Oct;14(5):424-7.
9. Kim DM, Lee IH, Song CJ. Uremic Encephalopathy: MR Imaging Findings and Clinical Correlation. AJNR Am J Neuroradiol. 2016 Sep; 37 (9):1604-9.
10. Kang E, Jeon SJ, Choi S-S. Uremic encephalopathy with atypical magnetic resonance features on diffusion weighted images. Korean j Radiol. 2012 Nov-Dec; 13(6): 808-811
11. Yoon CH, Seok JI, Lee DK, An GS. Bilateral basal ganglia and unilateral cortical involvement in a diabetic uremic patient. Clin Neurol Neurosurg. 2009;111:477–479.
12. Raskin NH. Neurological complications of renal failure. In: Aminoff MJ, editor. Neurology and general medicine. New York: Churchill Livingstone; 1995. pp. 303–319.
13. Raskin NH, Fishman RA. Neurologic disorders in renal failure (first of two parts) N Engl J Med. 1976;294:143–148.